185 related articles for article (PubMed ID: 20802016)
1. Radiation-guided drug delivery to mouse models of lung cancer.
Hariri G; Yan H; Wang H; Han Z; Hallahan DE
Clin Cancer Res; 2010 Oct; 16(20):4968-77. PubMed ID: 20802016
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Lim SH; Li CH; Jeong YI; Jang WY; Choi JM; Jung S
Int J Nanomedicine; 2019; 14():8861-8874. PubMed ID: 32009784
[TBL] [Abstract][Full Text] [Related]
3. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
Hariri G; Edwards AD; Merrill TB; Greenbaum JM; van der Ende AE; Harth E
Mol Pharm; 2014 Jan; 11(1):265-75. PubMed ID: 24215299
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
Zhou Q; Ching AK; Leung WK; Szeto CY; Ho SM; Chan PK; Yuan YF; Lai PB; Yeo W; Wong N
Int J Oncol; 2011 Mar; 38(3):721-31. PubMed ID: 21240457
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery.
Fu Q; Sun J; Zhang W; Sui X; Yan Z; He Z
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):262-72. PubMed ID: 19538176
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model.
Bressand D; Novell A; Girault A; Raoul W; Fromont-Hankard G; Escoffre JM; Lecomte T; Bouakaz A
Mol Pharm; 2019 Sep; 16(9):3814-3822. PubMed ID: 31356090
[TBL] [Abstract][Full Text] [Related]
7. Radiation-Guided Peptide Delivery in a Mouse Model of Nasopharyngeal Carcinoma.
Lin PC; He JY; Le YY; Du KX; Zhu WF; Peng QQ; Dong YP; Li JL; Wu JX
Biomed Res Int; 2016; 2016():5382047. PubMed ID: 27738632
[No Abstract] [Full Text] [Related]
8. SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts.
Kim H; Samuel S; Lopez-Casas P; Grizzle W; Hidalgo M; Kovar J; Oelschlager D; Zinn K; Warram J; Buchsbaum D
Mol Cancer Ther; 2016 Apr; 15(4):680-8. PubMed ID: 26832793
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.
Lowery A; Onishko H; Hallahan DE; Han Z
J Control Release; 2011 Feb; 150(1):117-24. PubMed ID: 21075152
[TBL] [Abstract][Full Text] [Related]
10. Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate.
Gao M; Zhang D; Yao N; Jin Q; Jiang C; Zhang J; Wang F
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1187-1194. PubMed ID: 31520101
[TBL] [Abstract][Full Text] [Related]
11. S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.
Suenaga M; Yamada S; Fujii T; Tanaka C; Kanda M; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Surg Oncol; 2016 Mar; 113(4):413-9. PubMed ID: 27100026
[TBL] [Abstract][Full Text] [Related]
12. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R
Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955
[TBL] [Abstract][Full Text] [Related]
13. nab-Paclitaxel mechanisms of action and delivery.
Yardley DA
J Control Release; 2013 Sep; 170(3):365-72. PubMed ID: 23770008
[TBL] [Abstract][Full Text] [Related]
14. Nab-Paclitaxel Plus S-1 Shows Increased Antitumor Activity in Patient-Derived Pancreatic Cancer Xenograft Mouse Models.
Li JA; Xu XF; Han X; Fang Y; Shi CY; Jin DY; Lou WH
Pancreas; 2016 Mar; 45(3):425-33. PubMed ID: 26495780
[TBL] [Abstract][Full Text] [Related]
15. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S
Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
18. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
[TBL] [Abstract][Full Text] [Related]
19. PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.
Kapoor V; Singh AK; Rogers BE; Thotala D; Hallahan DE
J Control Release; 2019 Mar; 298():194-201. PubMed ID: 30763622
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.
Passarella RJ; Spratt DE; van der Ende AE; Phillips JG; Wu H; Sathiyakumar V; Zhou L; Hallahan DE; Harth E; Diaz R
Cancer Res; 2010 Jun; 70(11):4550-9. PubMed ID: 20484031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]